Drug development experts continue to wrestle with the concept of the Design Space. Someone with a knack for explaining complex concepts such as Design Space in plain terms is Bikash Chatterjee, CTO of Pharmatech Associates. As such, we’ve pulled the videos below, in which Bikash tackles questions related to Design Space, out of our vaults.

Design Space Dilemmas
Why Design Space is such a source of frustration, and how to approach it.

Design Space: Whose Job?
Whose job is it to define the Design Space and be its caretaker?

DS-based Projects
How can the Design Space be used to help shape and drive a project, across functions?

–Paul Thomas

Related posts:

1. QbD Classics: What Your ICH Q8 Design Space Needs

   In this classic article, GSK's John Peterson argues that we must use multivariate predictive distribution to understand randomness and think...

2. Staying Within the Lines? Interpolation vs. Extrapolation in the Design Space

   A presentation at IFPAC last Thursday brought on some heated debate about the Design Space, and just how dynamic it...

3. A Very Brief History of the Dynamic Design Space

   The concept of a dynamic design space has been around for a while at least on the API side, where...

4. Video: What Do Pharmaceutical Manufacturers Really Need to Know about ICH Q8R?

   Insights from our QbD Chat video series, with Bikash Chatterjee of Pharmatech Associates....

5. Winning the Space Race

   ICH Q8 and the QbD guidance issued by the FDA offer pharmaceutical manufacturers a significant opportunity to design quality into...